(NASDAQ: EDSA) Edesa Biotech's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 24.3%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 67.39%.
Edesa Biotech's earnings in 2026 is -$10,443,823.On average, 5 Wall Street analysts forecast EDSA's earnings for 2026 to be -$14,829,107, with the lowest EDSA earnings forecast at -$20,042,458, and the highest EDSA earnings forecast at -$9,056,452. On average, 4 Wall Street analysts forecast EDSA's earnings for 2027 to be -$15,781,435, with the lowest EDSA earnings forecast at -$24,312,372, and the highest EDSA earnings forecast at -$6,442,218.
In 2028, EDSA is forecast to generate -$11,745,378 in earnings, with the lowest earnings forecast at -$17,776,788 and the highest earnings forecast at -$5,135,102.